LKFTLakefront Biotherapeutics American Depositary Shares

28.80USDMkt Cap: 1.89B $P/E: 2.76

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a ph…

Key Statistics

Company
Market Cap1.89B $
Enterprise Value36.32B $
Revenue (TTM)990.57M $
Gross Profit1.08B $
Net Income (TTM)320.88M $
Revenue/Share0.7517 USD
Last Price28.80 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees452
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)2.76
P/E (Forward)-20.46
PEG
EV/EBITDA63.84
EV/Revenue36.67
P/S1.87
P/B9.89
EPS (TTM)10.05
EPS (Forward)-1.38
52W Range
28.1662% of range29.20
52W High29.20 USD
52W Low28.16 USD
Profitability
Gross Margin97.33%
Oper. Margin-359.30%
EBITDA Margin57.43%
Profit Margin28.85%
ROE9.92%
ROA9.42%
Growth
Revenue Growth-81.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-257.46M $
CapEx (TTM)13.86M $
FCF Margin13.95%
FCF Yield7.33%
Net Debt-2.23B $
Net Debt/EBITDA-3.93
Balance Sheet
Debt/Equity0.00
Current Ratio32.84
Quick Ratio32.65
Book Value/Sh2.858 USD
Cash/Share1.706 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating3.4 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)23.91 USD
Upside (mean)-17.0%
Target Range19.11 USD26.31 USD
$19.11-17.0% to mean$26.31
# Analysts3
Ownership
Shares Out.65.48M
Float486.05M
Insiders25.45%
Institutions23.64%
Short Interest
Short Ratio15.1d
Short % Float6.30%
Short % Out.3.85%
Shares Short2.52M
Short (prev mo.)2.24M
Technical
SMA 5028.65 (+0.5%)
SMA 20030.54 (-5.7%)
Beta0.11
S&P 52W Chg21.00%
Avg Vol (30d)263.58K
Avg Vol (10d)322.76K
Technical Indicators
RSI (14)55.0
MACD-0.0126
MACD Signal-0.2445
MACD Hist.+0.2319
BB Upper29.38 USD
BB Middle27.62 USD
BB Lower25.85 USD
BB Width12.80%
ATR (14)0.8386 USD
Vol Ratio (20d)0.99x